Illustrative NFuze-branded BPC 157 vial

Consultation First

Peptides

A conversation before a prescription.

Begin with a consultation to discuss peptides and prescription requirements. A licensed provider will review your goals, health history, the evidence and potential risks. Any prescription depends on clinical suitability and current legal availability, not simply your choice of peptide.

Your Health First

Discuss your goals, health history and medications with a licensed provider.

Evidence & Safety

Review the limits of the evidence, potential risks and legally available options.

Prescription Review

A consultation does not guarantee a prescription. Suitability and availability require provider review.

Peptide Consultations

Start With Your Questions

Bring questions about these peptides to your consultation. There are no preset doses, prices or treatment plans to choose here.

Illustrative NFuze-branded BPC 157 vial

Prescription Consultation

BPC 157

Discuss BPC 157, the available evidence and whether a legally available option is appropriate for you.

Book Now
Illustrative NFuze-branded TB 500 vial

Prescription Consultation

TB 500

Discuss TB 500, the available evidence and whether a legally available option is appropriate for you.

Book Now
Illustrative NFuze-branded GHK-cu vial

Prescription Consultation

GHK-cu

Discuss GHK-cu, the available evidence and whether a legally available option is appropriate for you.

Book Now
Illustrative NFuze-branded KPV vial

Prescription Consultation

KPV

Discuss KPV, the available evidence and whether a legally available option is appropriate for you.

Book Now

Vial images are illustrative NFuze mockups, not actual dispensed products. These peptides are not FDA-approved treatments; human safety and effectiveness evidence is limited. Listing a peptide does not establish that it can legally be prescribed or compounded. Your provider will review current requirements and appropriate alternatives.

Combination Stacks

Two, Three or Four Peptides

Illustrative groupings for discussion only, not recommended combinations, blended formulations or available packages. Combining peptides may introduce additional risks.

BPC 157 illustrative vialTB 500 illustrative vial

2-Peptide Illustration

BPC 157 + TB 500

For a provider-led discussion, not a preselected prescription.

BPC 157 illustrative vialGHK-cu illustrative vial

2-Peptide Illustration

BPC 157 + GHK-cu

For a provider-led discussion, not a preselected prescription.

BPC 157 illustrative vialKPV illustrative vial

2-Peptide Illustration

BPC 157 + KPV

For a provider-led discussion, not a preselected prescription.

TB 500 illustrative vialGHK-cu illustrative vial

2-Peptide Illustration

TB 500 + GHK-cu

For a provider-led discussion, not a preselected prescription.

TB 500 illustrative vialKPV illustrative vial

2-Peptide Illustration

TB 500 + KPV

For a provider-led discussion, not a preselected prescription.

GHK-cu illustrative vialKPV illustrative vial

2-Peptide Illustration

GHK-cu + KPV

For a provider-led discussion, not a preselected prescription.

Have questions about peptides?

Book a consultation to discuss the evidence, risks and current prescription requirements with a provider.

The NFuze team will follow up about availability.